Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchEnded earlyNCT04150874
What this trial is testing

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute 4
Not applicableLooking for participantsNCT07280390
What this trial is testing

Microplastics, Cirrhosis and Portal Hypertension

Who this might be right for
CirrhosisMicroplasticsPortal Hypertension Related to Cirrhosis+3 more
Post Graduate Institute of Medical Education and Research, Chandigarh 30
Not applicableStudy completedNCT06199297
What this trial is testing

Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 188
Early research (Phase 1)Study completedNCT01631097
What this trial is testing

A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic Impairment
AVEO Pharmaceuticals, Inc. 44
Not applicableStudy completedNCT04709718
What this trial is testing

Surgical Management of Giant Hepatic Hemangioma

Who this might be right for
Liver Angioma
Université de Sousse 12
Early research (Phase 1)UnknownNCT00935454
What this trial is testing

Hepatocyte Matrix Implant Study

Who this might be right for
Liver DiseaseLiver Cirrhosis
Baermed 10
Not applicableStudy completedNCT03641872
What this trial is testing

A Validation Cohort for ACLF Diagnosis and Prognosis

Who this might be right for
Liver Failure, Acute on ChronicLiver Dysfunction
Hai Li 1,370
Not applicableStudy completedNCT02922751
What this trial is testing

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

Who this might be right for
Biliary AtresiaAlagille SyndromeAlpha1 Anti-Trypsin Deficiency+3 more
Arbor Research Collaborative for Health 552
Not applicableStudy completedNCT01551966
What this trial is testing

Esophageal Capsule Endoscopy in Children

Who this might be right for
Portal HypertensionCirrhosis
Hospices Civils de Lyon 100
Large-scale testing (Phase 3)Study completedNCT02284256
What this trial is testing

A Safety and Efficacy Study Comparing Fibrocaps and Tachosil in Hepatic Surgery

Who this might be right for
Surgical Bleeding
Mallinckrodt 150
Early research (Phase 1)Study completedNCT00419237
What this trial is testing

Investigating The Pharmacokinetics Of An Inhaled Dose Of A New Corticosteroid In Patients With Impaired Liver Function

Who this might be right for
Asthma
GlaxoSmithKline 20
Early research (Phase 1)Study completedNCT01625351
What this trial is testing

CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

Who this might be right for
Ewing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more
St. Jude Children's Research Hospital 23
Post-approval studies (Phase 4)UnknownNCT03987893
What this trial is testing

PEG3350 in ACLF With Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyAcute-On-Chronic Liver Failure
Post Graduate Institute of Medical Education and Research, Chandigarh 60
Early research (Phase 1)Study completedNCT01916993
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic Insufficiency

Who this might be right for
Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects
Neurocrine Biosciences 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07570914
What this trial is testing

Hepatic Arterial Infusion of Liposomal Irinotecan Plus Oxaliplatin and Capecitabine as Adjuvant Therapy for Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)Colorectal CancerLiver Metastasis
Tianjin Medical University Cancer Institute and Hospital 28
Testing effectiveness (Phase 2)Study completedNCT00030563
What this trial is testing

Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
University of Washington
Not applicableEnded earlyNCT05411263
What this trial is testing

Portal Vein Flow Variability to Quantify Right-Sided Hemodynamic Congestion (PORTAL)

Who this might be right for
CongestionHeart FailureRight Heart Catheterisation+2 more
Vrije Universiteit Brussel 61
Post-approval studies (Phase 4)Study completedNCT02247414
What this trial is testing

Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection

Who this might be right for
CirrhosisHypertensionStatus;Splenectomy+1 more
Yangzhou University 124
Not applicableLooking for participantsNCT04096014
What this trial is testing

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
The Cleveland Clinic 40
Not applicableStudy completedNCT00887887
What this trial is testing

The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery

Who this might be right for
Liver Disease
Maastricht University Medical Center 100
Next Page